Technological advances in mass spectrometry–based lipidomic platforms have provided the
opportunity for comprehensive profiling of lipids in biological samples and shown alterations
in the lipidome that occur in metabolic disorders. A lipidomic approach serves as a powerful
tool for biomarker discovery and gaining insight to molecular mechanisms of disease,
especially when integrated with other-omics platforms (ie, transcriptomics, proteomics, and
metabolomics) in the context of systems biology. In this review, we describe the workflow …